{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:21:21Z","timestamp":1747207281677,"version":"3.40.5"},"reference-count":149,"publisher":"Bentham Science Publishers Ltd.","issue":"16","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2019,11,13]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Amylin is a neuroendocrine peptide hormone secreted by pancreatic &amp;#223;-cells; however,\namylin is toxic to &amp;#223;-cells when it is aggregated in type 2 diabetes mellitus (T2DM). It is important to\nunderstand amylin\u2019s structures and aggregation mechanism for the discovery and design of effective\ndrugs to inhibit amylin aggregation. In this review, we investigated experimental and computational\nstudies on amylin structures and inhibitors. Our review provides some novel insights into amylin, particularly\nfor the design of its aggregation inhibitors to treat T2DM. We detailed the potential inhibitors\nthat have been studied hitherto and highlighted the neglected need to consider different amylin attributes\nthat depend on the presence\/absence of physiologically relevant conditions, such as membranes.\nThese conditions and the experimental methods can greatly influence the results of studies on amylininhibitor\ncomplexes. Text-mining over 3,000 amylin-related PubMed abstracts suggests the combined\ntherapeutic potential of amylin with leptin and glucagon-like peptide-1, which are two key hormones\nin obesity. The results also suggest that targeting amylin aggregation can contribute to therapeutic efforts\nfor Alzheimer\u2019s disease (AD). Therefore, we have also reviewed the role of amylin in other conditions\nincluding obesity and AD. Finally, we provided insights for designing inhibitors of different\ntypes (small molecules, proteins, peptides\/mimetics, metal ions) to inhibit amylin aggregation.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389450120666190719164316","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T08:48:51Z","timestamp":1563871731000},"page":"1680-1694","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Computational and Experimental Approaches to Design Inhibitors of Amylin Aggregation"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1989-1037","authenticated-orcid":true,"given":"Ammu Prasanna","family":"Kumar","sequence":"first","affiliation":[{"name":"Department of Chemistry, College of Arts and Sciences, Khalifa University, Abu Dhabi, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1699-8376","authenticated-orcid":true,"given":"Sungmun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering and Healthcare Engineering Innovation Center, College of Engineering, Khalifa University, Abu Dhabi, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8913-1343","authenticated-orcid":true,"given":"Suryani","family":"Lukman","sequence":"additional","affiliation":[{"name":"Department of Chemistry, College of Arts and Sciences, Khalifa University, Abu Dhabi, United Arab Emirates"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.molmed.2015.04.005","volume":"21","author":"Mukherjee A.","year":"2015","unstructured":"Mukherjee A.; Morales-Scheihing D.; Butler P.C.; Soto C.; Type 2 diabetes as a protein misfolding disease. Trends Mol Med 2015,21(7),439-449","journal-title":"Trends Mol Med"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.febslet.2013.01.017","volume":"587","author":"Abedini A.","year":"2013","unstructured":"Abedini A.; Schmidt A.M.; Mechanisms of islet amyloidosis toxicity in type 2 diabetes. FEBS Lett 2013,587(8),1119-1127","journal-title":"FEBS Lett"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1073\/pnas.96.7.3342","volume":"96","author":"Lansbury PT","unstructured":"Lansbury PT;  Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease Proc Natl Acad Sci U S A 1999,96(7),3342-4","journal-title":"Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease Proc Natl Acad Sci U S A"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3109\/10408369409084679","volume":"31","author":"Sipe J.D.","year":"1994","unstructured":"Sipe J.D.; Cohen A.S.; Amyloidosis. Crit Rev Clin Lab Sci 1994,31(4),325-354","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1146\/annurev.bi.61.070192.004503","volume":"61","author":"Sipe J.D.","year":"1992","unstructured":"Sipe J.D.; Amyloidosis. Annu Rev Biochem 1992,61(1),947-975","journal-title":"Annu Rev Biochem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1126\/science.271.5255.1493","volume":"271","author":"Taubes G.","year":"1996","unstructured":"Taubes G.; Misfolding the way to disease. Science 1996,271(5255),1493-1495","journal-title":"Science"},{"key":"ref=7","first-page":"16","volume":"1502","author":"Serpell LC","unstructured":"Serpell LC;  Alzheimer\u2019s amyloid fibrils: structure and assembly Biochim Biophys Acta - Mol Basis Dis 2000,1502(1),16-30","journal-title":"Alzheimer\u2019s amyloid fibrils: structure and assembly Biochim Biophys Acta - Mol Basis Dis"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0022-2836(03)00687-9","volume":"330","author":"Smith DP","unstructured":"Smith DP; Jones S; Serpell LC; Sunde M; Radford SE; a systematic\n\tinvestigation into the effect of protein destabilisation on beta 2-\n\tmicroglobulin amyloid formation. J Mol Biol Academic Press 2003,330(5),943-54","journal-title":"J Mol Biol Academic Press"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"4897","DOI":"10.1073\/pnas.97.9.4897","volume":"97","author":"Serpell L.C.","year":"2000","unstructured":"Serpell L.C.; Berriman J.; Jakes R.; Goedert M.; Crowther R.A.; Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. Proc Natl Acad Sci USA 2000,97(9),4897-4902","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jmb.2004.02.056","volume":"338","author":"Jansen R.","year":"2004","unstructured":"Jansen R.; Grudzielanek S.; Dzwolak W.; Winter R.; High pressure promotes circularly shaped insulin amyloid. J Mol Biol 2004,338(2),203-206","journal-title":"J Mol Biol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"16742","DOI":"10.1073\/pnas.262663499","volume":"99","author":"Petkova A.T.","year":"2002","unstructured":"Petkova A.T.; Ishii Y.; Balbach J.J.; A structural model for Alzheimer\u2019s beta -amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci USA 2002,99(26),16742-16747","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1073\/pnas.0337745100","volume":"100","author":"Thompson LK","unstructured":"Thompson LK;  Unraveling the secrets of Alzheimer\u2019s beta-amyloid fibrils Proc Natl Acad Sci USA 2003,100(2),383-5","journal-title":"Unraveling the secrets of Alzheimer\u2019s beta-amyloid fibrils Proc Natl Acad Sci USA"},{"author":"User S.","unstructured":"User S.;","key":"ref=13"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1001\/jama.2017.0241","volume":"317","author":"Reusch J.E.B.","year":"2017","unstructured":"Reusch J.E.B.; Manson J.E.; Management of Type 2 Diabetes in 2017: Getting to Goal. JAMA 2017,317(10),1015-1016","journal-title":"JAMA"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1177\/2040622314548679","volume":"5","author":"Wilmot E.","year":"2014","unstructured":"Wilmot E.; Idris I.; Early onset type 2 diabetes: risk factors, clinical impact and management. Ther Adv Chronic Dis 2014,5(6),234-244","journal-title":"Ther Adv Chronic Dis"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.2337\/diacare.27.7.1798","volume":"27","author":"Alberti G.","year":"2004","unstructured":"Alberti G.; Zimmet P.; Shaw J.; Bloomgarden Z.; Kaufman F.; Silink M.; Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop. Diabetes Care 2004,27(7),1798-1811","journal-title":"Diabetes Care"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.3109\/02841869109092400","volume":"30","author":"Stridsberg M.","year":"1991","unstructured":"Stridsberg M.; Wilander E.; Islet amyloid polypeptide (IAPP). A short review. Acta Oncol 1991,30(4),451-456","journal-title":"Acta Oncol"},{"key":"ref=18","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2798269","volume":"2016","author":"Akter R.","year":"2016","unstructured":"Akter R.; Cao P.; Noor H.; Islet amyloid polypeptide: structure, function, and pathophysiology. J Diabetes Res 2016,2016","journal-title":"J Diabetes Res"},{"key":"ref=19","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5639875","author":"Caillon L.","year":"2016","unstructured":"Caillon L.; Hoffmann A.R.F.; Botz A.; Khemtemourian L.; Molecular structure, membrane interactions, and toxicity of the islet amyloid polypeptide in type 2 diabetes mellitus. J Diabetes Res 2016","journal-title":"J Diabetes Res"},{"key":"ref=20","doi-asserted-by":"publisher","DOI":"10.1098\/rsfs.2016.0127","volume":"7","author":"Obasse I.","year":"2017","unstructured":"Obasse I.; Taylor M.; Fullwood N.J.; Allsop D.; Development of proteolytically stable N-methylated peptide inhibitors of aggregation of the amylin peptide implicated in type 2 diabetes. Interface Focus 2017,7(6)","journal-title":"Interface Focus"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2174\/1389450053174596","volume":"6","author":"Lutz T.A.","year":"2005","unstructured":"Lutz T.A.; Pancreatic amylin as a centrally acting satiating hormone. Curr Drug Targets 2005,6(2),181-189","journal-title":"Curr Drug Targets"},{"year":"2013","author":"Roberson S.W.","unstructured":"Roberson S.W.;  2013","key":"ref=22"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1124\/pr.115.010629","volume":"67","author":"Hay D.L.","year":"2015","unstructured":"Hay D.L.; Chen S.; Lutz T.A.; Parkes D.G.; Roth J.D.; Amylin: pharmacology, physiology, and clinical potential. Pharmacol Rev 2015,67(3),564-600","journal-title":"Pharmacol Rev"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1210\/er.2007-0037","volume":"29","author":"Haataja L.","year":"2008","unstructured":"Haataja L.; Gurlo T.; Huang C.J.; Butler P.C.; Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr Rev 2008,29(3),303-316","journal-title":"Endocr Rev"},{"key":"ref=25","doi-asserted-by":"publisher","DOI":"10.3390\/cells7080095","author":"Kiriyama Y","year":"2018","unstructured":"Kiriyama Y; Nochi H; Role and cytotoxicity of amylin and protection of pancreatic islet \u03b2-cells from amylin cytotoxicity  Cells Multidisciplinary Digital Publishing Institute (MDPI) 7(8) . 2018"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2174\/13892037113149990050","volume":"14","author":"Westermark G.T.","year":"2013","unstructured":"Westermark G.T.; Westermark P.; Islet amyloid polypeptide and diabetes. Curr Protein Pept Sci 2013,14(4),330-337","journal-title":"Curr Protein Pept Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1586\/14789450.2015.1104251","volume":"12","author":"Ly H.","year":"2015","unstructured":"Ly H.; Despa F.; Hyperamylinemia as a risk factor for accelerated cognitive decline in diabetes. Expert Rev Proteomics 2015,12(6),575-577","journal-title":"Expert Rev Proteomics"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.14740\/jem302w","volume":"5","author":"Lukman S.","year":"2015","unstructured":"Lukman S.; Al Safar H.; Lee S.M.; Sim K.; Harnessing Structural Data of Insulin and Insulin Receptor for Therapeutic Designs. J Endocrinol Metab 2015,5(5),273-283","journal-title":"J Endocrinol Metab"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"13505","DOI":"10.1021\/bi701427q","volume":"46","author":"Luca S.","year":"2007","unstructured":"Luca S.; Yau W-M.; Leapman R.; Tycko R.; Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. Biochemistry 2007,46(47),13505-13522","journal-title":"Biochemistry"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"15871","DOI":"10.1073\/pnas.0506109102","volume":"102","author":"Heise H.","year":"2005","unstructured":"Heise H.; Hoyer W.; Becker S.; Andronesi O.C.; Riedel D.; Baldus M.; Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR. Proc Natl Acad Sci USA 2005,102(44),15871-15876","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"17342","DOI":"10.1073\/pnas.0506723102","volume":"102","author":"L\u00fchrs T.","year":"2005","unstructured":"L\u00fchrs T.; Ritter C.; Adrian M.; 3D structure of Alzheimer\u2019s amyloid-beta(1-42) fibrils. Proc Natl Acad Sci USA 2005,102(48),17342-17347","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"8637","DOI":"10.1073\/pnas.0712179105","volume":"105","author":"Vilar M.","year":"2008","unstructured":"Vilar M.; Chou H-T.; L\u00fchrs T.; The fold of alpha-synuclein fibrils. Proc Natl Acad Sci USA 2008,105(25),8637-8642","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1016\/j.bbamem.2011.06.012","volume":"1808","author":"Nanga R.P.R.","year":"2011","unstructured":"Nanga R.P.R.; Brender J.R.; Vivekanandan S.; Ramamoorthy A.; Structure and membrane orientation of IAPP in its natively amidated form at physiological pH in a membrane environment. Biochim Biophys Acta 2011,1808(10),2337-2342","journal-title":"Biochim Biophys Acta"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"18283","DOI":"10.1021\/ja903814q","volume":"131","author":"Dupuis N.F.","year":"2009","unstructured":"Dupuis N.F.; Wu C.; Shea J-E.; Bowers M.T.; Human islet amyloid polypeptide monomers form ordered beta-hairpins: a possible direct amyloidogenic precursor. J Am Chem Soc 2009,131(51),18283-18292","journal-title":"J Am Chem Soc"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"7240","DOI":"10.1021\/ja1081537","volume":"133","author":"Dupuis N.F.","year":"2011","unstructured":"Dupuis N.F.; Wu C.; Shea J-E.; Bowers M.T.; The amyloid formation mechanism in human IAPP: dimers have \u03b2-strand monomer-monomer interfaces. J Am Chem Soc 2011,133(19),7240-7243","journal-title":"J Am Chem Soc"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1016\/j.bpj.2010.07.014","volume":"99","author":"Reddy A.S.","year":"2010","unstructured":"Reddy A.S.; Wang L.; Singh S.; Stable and metastable states of human amylin in solution. Biophys J 2010,99(7),2208-2216","journal-title":"Biophys J"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"6","DOI":"10.7554\/eLife.31226","volume":"6","author":"Rodriguez Camargo D.C.","year":"2017","unstructured":"Rodriguez Camargo D.C.; Korshavn K.J.; Jussupow A.; Stabilization and structural analysis of a membrane-associated hIAPP aggregation intermediate. eLife 2017,6(Nov),6","journal-title":"eLife"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"33474","DOI":"10.1038\/srep33474","volume":"6","author":"Mirecka E.A.","year":"2016","unstructured":"Mirecka E.A.; Feuerstein S.; Gremer L.; \u03b2-Hairpin of islet amyloid polypeptide bound to an aggregation inhibitor. Sci Rep 2016,6,33474","journal-title":"Sci Rep"},{"key":"ref=39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2018.03.027","author":"Rawat A","year":"2018","unstructured":"Rawat A; Maity BK; Chandra B; Maiti S; Aggregation-induced\n\tconformation changes dictate islet amyloid polypeptide (IAPP)\n\tmembrane affinity. Biochim Biophys Acta Biomembr  S0005-2736(18)30107-X2018"},{"key":"ref=40","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/918573","volume":"2015","author":"Tomasello M.F.","year":"2015","unstructured":"Tomasello M.F.; Sinopoli A.; Pappalardo G.; On the environmental factors affecting the structural and cytotoxic properties of iapp peptides. J Diabetes Res 2015,2015","journal-title":"J Diabetes Res"},{"key":"ref=41","first-page":"1873","volume":"10","author":"Jeong H.R.","year":"2015","unstructured":"Jeong H.R.; An S.S.A.; Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus. Clin Interv Aging 2015,10,1873-1879","journal-title":"Clin Interv Aging"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"12666","DOI":"10.1074\/jbc.M109229200","volume":"277","author":"Souillac P.O.","year":"2002","unstructured":"Souillac P.O.; Uversky V.N.; Millett I.S.; Khurana R.; Doniach S.; Fink A.L.; Elucidation of the molecular mechanism during the early events in immunoglobulin light chain amyloid fibrillation. Evidence for an off-pathway oligomer at acidic pH. J Biol Chem 2002,277(15),12666-12679","journal-title":"J Biol Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/1097-0282(2001)60:5<381:AID-BIP10173>3.0.CO;2-U","volume":"60","author":"Gorman P.M.","year":"2001","unstructured":"Gorman P.M.; Chakrabartty A.; Alzheimer \u03b2-amyloid peptides: structures of amyloid fibrils and alternate aggregation products. Biopolymers 2001,60(5),381-394","journal-title":"Biopolymers"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1146\/annurev.bioeng.4.092801.094202","volume":"4","author":"Murphy R.M.","year":"2002","unstructured":"Murphy R.M.; Peptide aggregation in neurodegenerative disease. Annu Rev Biomed Eng 2002,4(1),155-174","journal-title":"Annu Rev Biomed Eng"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/S0006-3495(01)75831-6","volume":"81","author":"Pallitto M.M.","year":"2001","unstructured":"Pallitto M.M.; Murphy R.M.; A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state. Biophys J 2001,81(3),1805-1822","journal-title":"Biophys J"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1021\/bi00069a001","volume":"32","author":"Jarrett J.T.","year":"1993","unstructured":"Jarrett J.T.; Berger E.P.; Lansbury P.T.; The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer\u2019s disease. Biochemistry 1993,32(18),4693-4697","journal-title":"Biochemistry"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.bbapap.2010.04.001","volume":"1804","author":"Biancalana M.","year":"2010","unstructured":"Biancalana M.; Koide S.; Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim Biophys Acta 2010,1804(7),1405-1412","journal-title":"Biochim Biophys Acta"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/0003-9861(92)90735-F","volume":"294","author":"Tomski S.J.","year":"1992","unstructured":"Tomski S.J.; Murphy R.M.; Kinetics of aggregation of synthetic beta-amyloid peptide. Arch Biochem Biophys 1992,294(2),630-638","journal-title":"Arch Biochem Biophys"},{"key":"ref=49","first-page":"247","volume":"122","author":"Inouye H","unstructured":"Inouye H; Kirschner DA; Polypeptide chain folding in the hydrophobic\n\tcore of hamster scrapie prion: analysis by x-ray diffraction.\n\tJ Struct Biol Academic Press 1998,122(1\u20132),247-55"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"6424","DOI":"10.1021\/ja710484d","volume":"130","author":"Brender J.R.","year":"2008","unstructured":"Brender J.R.; Lee E.L.; Cavitt M.A.; Gafni A.; Steel D.G.; Ramamoorthy A.; Amyloid fiber formation and membrane disruption are separate processes localized in two distinct regions of IAPP, the type-2-diabetes-related peptide. J Am Chem Soc 2008,130(20),6424-6429","journal-title":"J Am Chem Soc"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2337\/db06-0734","volume":"56","author":"Ritzel R.A.","year":"2007","unstructured":"Ritzel R.A.; Meier J.J.; Lin C-Y.; Veldhuis J.D.; Butler P.C.; Human islet amyloid polypeptide oligomers disrupt cell coupling, induce apoptosis, and impair insulin secretion in isolated human islets. Diabetes 2007,56(1),65-71","journal-title":"Diabetes"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"12206","DOI":"10.1074\/jbc.M312452200","volume":"279","author":"Green J.D.","year":"2004","unstructured":"Green J.D.; Goldsbury C.; Kistler J.; Cooper G.J.S.; Aebi U.; Human amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation. J Biol Chem 2004,279(13),12206-12212","journal-title":"J Biol Chem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1038\/srep02781","volume":"3","author":"Pannuzzo M.","year":"2013","unstructured":"Pannuzzo M.; Raudino A.; Milardi D.; La Rosa C.; Karttunen M.; \u03b1-helical structures drive early stages of self-assembly of amyloidogenic amyloid polypeptide aggregate formation in membranes. Sci Rep 2013,3,2781","journal-title":"Sci Rep"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1096\/fj.11-194613","volume":"26","author":"Magzoub M.","year":"2012","unstructured":"Magzoub M.; Miranker A.D.; Concentration-dependent transitions govern the subcellular localization of islet amyloid polypeptide. FASEB J 2012,26(3),1228-1238","journal-title":"FASEB J"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jmb.2005.12.020","volume":"356","author":"Engel M.F.M.","year":"2006","unstructured":"Engel M.F.M.; Yigittop H.; Elgersma R.C.; Islet amyloid polypeptide inserts into phospholipid monolayers as monomer. J Mol Biol 2006,356(3),783-789","journal-title":"J Mol Biol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0022-2836(02)00887-2","volume":"322","author":"Mazor Y.","year":"2002","unstructured":"Mazor Y.; Gilead S.; Benhar I.; Gazit E.; Identification and characterization of a novel molecular-recognition and self-assembly domain within the islet amyloid polypeptide. J Mol Biol 2002,322(5),1013-1024","journal-title":"J Mol Biol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"12689","DOI":"10.1021\/bi8014357","volume":"47","author":"Nanga R.P.R.","year":"2008","unstructured":"Nanga R.P.R.; Brender J.R.; Xu J.; Veglia G.; Ramamoorthy A.; Structures of rat and human islet amyloid polypeptide IAPP(1-19) in micelles by NMR spectroscopy. Biochemistry 2008,47(48),12689-12697","journal-title":"Biochemistry"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.chembiol.2009.08.013","volume":"16","author":"Hebda J.A.","year":"2009","unstructured":"Hebda J.A.; Saraogi I.; Magzoub M.; Hamilton A.D.; Miranker A.D.; A peptidomimetic approach to targeting pre-amyloidogenic states in type II diabetes. Chem Biol 2009,16(9),943-950","journal-title":"Chem Biol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1529\/biophysj.107.110635","volume":"93","author":"Lopes D.H.J.","year":"2007","unstructured":"Lopes D.H.J.; Meister A.; Gohlke A.; Hauser A.; Blume A.; Winter R.; Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy. Biophys J 2007,93(9),3132-3141","journal-title":"Biophys J"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jmb.2009.07.077","volume":"393","author":"Williamson J.A.","year":"2009","unstructured":"Williamson J.A.; Loria J.P.; Miranker A.D.; Helix stabilization precedes aqueous and bilayer-catalyzed fiber formation in islet amyloid polypeptide. J Mol Biol 2009,393(2),383-396","journal-title":"J Mol Biol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"9496","DOI":"10.1021\/bi060579z","volume":"45","author":"Knight J.D.","year":"2006","unstructured":"Knight J.D.; Hebda J.A.; Miranker A.D.; Conserved and cooperative assembly of membrane-bound alpha-helical states of islet amyloid polypeptide. Biochemistry 2006,45(31),9496-9508","journal-title":"Biochemistry"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.bbamem.2007.01.022","volume":"1768","author":"Jayasinghe S.A.","year":"2007","unstructured":"Jayasinghe S.A.; Langen R.; Membrane interaction of islet amyloid polypeptide. Biochim Biophys Acta 2007,1768(8),2002-2009","journal-title":"Biochim Biophys Acta"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.bbrc.2012.05.013","volume":"422","author":"Sparks S.","year":"2012","unstructured":"Sparks S.; Liu G.; Robbins K.J.; Lazo N.D.; Curcumin modulates the self-assembly of the islet amyloid polypeptide by disassembling \u03b1-helix. Biochem Biophys Res Commun 2012,422(4),551-555","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=64","first-page":"4267","volume":"4","author":"Bram Y.","year":"2015","unstructured":"Bram Y.; Frydman-Marom A.; Yanai I.; Gilead S.; Shaltiel-Karyo R.; Amdursky N.; Apoptosis induced by islet amyloid polypeptide soluble oligomers is neutralized by diabetes-associated specific antibodies. Sci Rep. Nature Publishing Group 2015,4(1),4267","journal-title":"Nature Publishing Group"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/protein\/gzm076","volume":"21","author":"Koo B.W.","year":"2008","unstructured":"Koo B.W.; Hebda J.A.; Miranker A.D.; Amide inequivalence in the fibrillar assembly of islet amyloid polypeptide. Protein Eng Des Sel 2008,21(3),147-154","journal-title":"Protein Eng Des Sel"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"19285","DOI":"10.1073\/pnas.1314481110","volume":"110","author":"Buchanan L.E.","year":"2013","unstructured":"Buchanan L.E.; Dunkelberger E.B.; Tran H.Q.; Mechanism of IAPP amyloid fibril formation involves an intermediate with a transient \u03b2-sheet. Proc Natl Acad Sci USA 2013,110(48),19285-19290","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"7915","DOI":"10.1038\/s41598-017-08504-x","volume":"7","author":"Liu N.","year":"2017","unstructured":"Liu N.; Duan M.; Yang M.; Structural Properties of Human IAPP Dimer in Membrane Environment Studied by All-Atom Molecular Dynamics Simulations. Sci Rep 2017,7(1),7915","journal-title":"Sci Rep"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1021\/bm2001507","volume":"12","author":"Zhao J.","year":"2011","unstructured":"Zhao J.; Yu X.; Liang G.; Zheng J.; Heterogeneous triangular structures of human islet amyloid polypeptide (amylin) with internal hydrophobic cavity and external wrapping morphology reveal the polymorphic nature of amyloid fibrils. Biomacromolecules 2011,12(5),1781-1794","journal-title":"Biomacromolecules"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1021\/bm501326y","volume":"16","author":"Wineman-Fisher V.","year":"2015","unstructured":"Wineman-Fisher V.; Atsmon-Raz Y.; Miller Y.; Orientations of residues along the \u03b2-arch of self-assembled amylin fibril-like structures lead to polymorphism. Biomacromolecules 2015,16(1),156-165","journal-title":"Biomacromolecules"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.1021\/bi800503j","volume":"47","author":"Radovan D.","year":"2008","unstructured":"Radovan D.; Smirnovas V.; Winter R.; Effect of pressure on islet amyloid polypeptide aggregation: revealing the polymorphic nature of the fibrillation process. Biochemistry 2008,47(24),6352-6360","journal-title":"Biochemistry"},{"key":"ref=71","doi-asserted-by":"publisher","DOI":"10.1103\/PhysRevE.84.041931","volume":"84","author":"Dias C.L.","year":"2011","unstructured":"Dias C.L.; Karttunen M.; Chan H.S.; Hydrophobic interactions in the formation of secondary structures in small peptides. Phys Rev E Stat Nonlin Soft Matter Phys 2011,84(4 Pt 1)","journal-title":"Phys Rev E Stat Nonlin Soft Matter Phys"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0014-5793(89)81467-X","volume":"251","author":"Betsholtz C.","year":"1989","unstructured":"Betsholtz C.; Christmansson L.; Engstr\u00f6m U.; Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains differences in islet amyloid formation between species. FEBS Lett 1989,251(1-2),261-264","journal-title":"FEBS Lett"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1006\/jmbi.2001.4593","volume":"308","author":"Jaikaran E.T.","year":"2001","unstructured":"Jaikaran E.T.; Higham C.E.; Serpell L.C.; Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis. J Mol Biol 2001,308(3),515-525","journal-title":"J Mol Biol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1006\/jmbi.1999.3422","volume":"295","author":"Tenidis K.","year":"2000","unstructured":"Tenidis K.; Waldner M.; Bernhagen J.; Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. J Mol Biol 2000,295(4),1055-1071","journal-title":"J Mol Biol"},{"key":"ref=75","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/256954","author":"Gilead S.","year":"2008","unstructured":"Gilead S.; Gazit E.; The role of the 14-20 domain of the islet amyloid polypeptide in amyloid formation. Exp Diabetes Res 2008","journal-title":"Exp Diabetes Res"},{"key":"ref=76","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/826706","volume":"2013","author":"Pillay K.","year":"2013","unstructured":"Pillay K.; Govender P.; Amylin uncovered: a review on the polypeptide responsible for type II diabetes. BioMed Res Int 2013,2013","journal-title":"BioMed Res Int"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.bbamem.2010.05.022","volume":"1798","author":"Khemt\u00e9mourian L.","year":"2010","unstructured":"Khemt\u00e9mourian L.; Engel M.F.M.; Liskamp R.M.J.; H\u00f6ppener J.W.M.; Killian J.A.; The N-terminal fragment of human islet amyloid polypeptide is non-fibrillogenic in the presence of membranes and does not cause leakage of bilayers of physiologically relevant lipid composition. Biochim Biophys Acta 2010,1798(9),1805-1811","journal-title":"Biochim Biophys Acta"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/bip.22650","volume":"104","author":"Louros N.N.","year":"2015","unstructured":"Louros N.N.; Tsiolaki P.L.; Zompra A.A.; Structural studies and cytotoxicity assays of \u201caggregation-prone\u201d IAPP(8-16) and its non-amyloidogenic variants suggest its important role in fibrillogenesis and cytotoxicity of human amylin. Biopolymers 2015,104(3),196-205","journal-title":"Biopolymers"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1021\/bm401406e","volume":"15","author":"Qi R.","year":"2014","unstructured":"Qi R.; Luo Y.; Ma B.; Nussinov R.; Wei G.; Conformational distribution and \u03b1-helix to \u03b2-sheet transition of human amylin fragment dimer. Biomacromolecules 2014,15(1),122-131","journal-title":"Biomacromolecules"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00249-010-0623-x","volume":"40","author":"Milardi D.","year":"2011","unstructured":"Milardi D.; Sciacca M.F.M.; Pappalardo M.; Grasso D.M.; La Rosa C.; The role of aromatic side-chains in amyloid growth and membrane interaction of the islet amyloid polypeptide fragment LANFLVH. Eur Biophys J 2011,40(1),1-12","journal-title":"Eur Biophys J"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1006\/jmbi.1999.3286","volume":"294","author":"Nilsson M.R.","year":"1999","unstructured":"Nilsson M.R.; Raleigh D.P.; Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin. J Mol Biol 1999,294(5),1375-1385","journal-title":"J Mol Biol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3109\/13506129.2012.762761","volume":"20","author":"Bruno E.","year":"2013","unstructured":"Bruno E.; Pereira C.; Roman K.P.; IAPP aggregation and cellular toxicity are inhibited by 1,2,3,4,6-penta-O-galloyl-\u03b2-D-glucose. Amyloid 2013,20(1),34-38","journal-title":"Amyloid"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1021\/acs.bioconjchem.8b00797","volume":"30","author":"Zhao L.","year":"2019","unstructured":"Zhao L.; Xin Y.; Li Y.; Yang X.; Luo L.; Meng F.; Ultraeffective inhibition of amyloid fibril assembly by nanobody-gold nanoparticle conjugates. Bioconjug Chem 2019,30(1),29-33","journal-title":"Bioconjug Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/cbic.201402552","volume":"16","author":"Shaykhalishahi H.","year":"2015","unstructured":"Shaykhalishahi H.; Mirecka E.A.; Gauhar A.; A \u03b2-hairpin-binding protein for three different disease-related amyloidogenic proteins. ChemBioChem 2015,16(3),411-414","journal-title":"ChemBioChem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1021\/acs.molpharmaceut.7b01009","volume":"15","author":"Azzam S.K.","year":"2018","unstructured":"Azzam S.K.; Jang H.; Choi M.C.; Alsafar H.; Lukman S.; Lee S.; Inhibition of Human Amylin Aggregation and Cellular Toxicity by Lipoic Acid and Ascorbic Acid. Mol Pharm 2018,15(6),2098-2106","journal-title":"Mol Pharm"},{"key":"ref=86","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17060964","volume":"17","author":"L\u00f3pez L.C.","year":"2016","unstructured":"L\u00f3pez L.C.; Varea O.; Navarro S.; Benzbromarone, quercetin, and folic acid inhibit amylin aggregation. Int J Mol Sci 2016,17(6)","journal-title":"Int J Mol Sci"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1021\/acschembio.5b00146","volume":"10","author":"Lopes D.H.J.","year":"2015","unstructured":"Lopes D.H.J.; Attar A.; Nair G.; Molecular tweezers inhibit islet amyloid polypeptide assembly and toxicity by a new mechanism. ACS Chem Biol 2015,10(6),1555-1569","journal-title":"ACS Chem Biol"},{"year":"2019","author":"Alghrably M","unstructured":"Alghrably M; Czaban I; Jaremko \u0141; Jaremko M.; Interaction of\n\tamylin species with transition metals and membranes. J Inorg Biochem\n\tElsevier 191(6): 69-762019","key":"ref=88"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1139\/cjpp-2015-0117","volume":"94","author":"Fortin J.S.","year":"2016","unstructured":"Fortin J.S.; Benoit-Biancamano M-O.; Inhibition of islet amyloid polypeptide aggregation and associated cytotoxicity by nonsteroidal anti-inflammatory drugs. Can J Physiol Pharmacol 2016,94(1),35-48","journal-title":"Can J Physiol Pharmacol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1021\/bi2015162","volume":"51","author":"Cao P.","year":"2012","unstructured":"Cao P.; Raleigh D.P.; Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols. Biochemistry 2012,51(13),2670-2683","journal-title":"Biochemistry"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"8127","DOI":"10.1021\/bi100939a","volume":"49","author":"Meng F.","year":"2010","unstructured":"Meng F.; Abedini A.; Plesner A.; Verchere C.B.; Raleigh D.P.; The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity. Biochemistry 2010,49(37),8127-8133","journal-title":"Biochemistry"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1021\/ja406831n","volume":"136","author":"Young L.M.","year":"2014","unstructured":"Young L.M.; Cao P.; Raleigh D.P.; Ashcroft A.E.; Radford S.E.; Ion mobility spectrometry-mass spectrometry defines the oligomeric intermediates in amylin amyloid formation and the mode of action of inhibitors. J Am Chem Soc 2014,136(2),660-670","journal-title":"J Am Chem Soc"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/s41598-017-18807-8","volume":"8","author":"Franko A.","year":"2018","unstructured":"Franko A.; Rodriguez Camargo D.C.; B\u00f6ddrich A.; Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice. Sci Rep 2018,8(1),1116","journal-title":"Sci Rep"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"33076","DOI":"10.1038\/srep33076","volume":"6","author":"Mo Y.","year":"2016","unstructured":"Mo Y.; Lei J.; Sun Y.; Zhang Q.; Wei G.; Conformational Ensemble of hIAPP Dimer: Insight into the Molecular Mechanism by which a Green Tea Extract inhibits hIAPP Aggregation. Sci Rep 2016,6,33076","journal-title":"Sci Rep"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"14781","DOI":"10.1021\/ja3031664","volume":"134","author":"Engel M.F.M.","year":"2012","unstructured":"Engel M.F.M.; vandenAkker CC, Schleeger M, Velikov KP, Koenderink GH, Bonn M. The polyphenol EGCG inhibits amyloid formation less efficiently at phospholipid interfaces than in bulk solution. J Am Chem Soc 2012,134(36),14781-14788","journal-title":"J Am Chem Soc"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejphar.2013.03.017","volume":"707","author":"Bahramikia S.","year":"2013","unstructured":"Bahramikia S.; Yazdanparast R.; Inhibition of human islet amyloid polypeptide or amylin aggregation by two manganese-salen derivatives. Eur J Pharmacol 2013,707(1-3),17-25","journal-title":"Eur J Pharmacol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/9062032","author":"Shi Y.","year":"2019","unstructured":"Shi Y.; Lv W.; Jiao A.; Zhang C.; Zhang J.;  A novel pentapeptide inhibitor reduces amyloid deposit formation by direct interaction with hiapp 2019,1-9","journal-title":"A novel pentapeptide inhibitor reduces amyloid deposit formation by direct interaction with hiapp"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1073\/pnas.0507471103","volume":"103","author":"Yan L-M.","year":"2006","unstructured":"Yan L-M.; Tatarek-Nossol M.; Velkova A.; Kazantzis A.; Kapurniotu A.; Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis. Proc Natl Acad Sci USA 2006,103(7),2046-2051","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/smll.201502317","volume":"12","author":"Gurzov E.N.","year":"2016","unstructured":"Gurzov E.N.; Wang B.; Pilkington E.H.; Inhibition of hIAPP Amyloid Aggregation and Pancreatic \u03b2-Cell Toxicity by OH-Terminated PAMAM Dendrimer. Small 2016,12(12),1615-1626","journal-title":"Small"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1110\/ps.036350.108","volume":"17","author":"Knight J.D.","year":"2008","unstructured":"Knight J.D.; Williamson J.A.; Miranker A.D.; Interaction of membrane-bound islet amyloid polypeptide with soluble and crystalline insulin. Protein Sci 2008,17(10),1850-1856","journal-title":"Protein Sci"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.jmb.2004.06.086","volume":"341","author":"Knight J.D.","year":"2004","unstructured":"Knight J.D.; Miranker A.D.; Phospholipid catalysis of diabetic amyloid assembly. J Mol Biol 2004,341(5),1175-1187","journal-title":"J Mol Biol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/pro.2023","volume":"21","author":"Noor H.","year":"2012","unstructured":"Noor H.; Cao P.; Raleigh D.P.; Morin hydrate inhibits amyloid formation by islet amyloid polypeptide and disaggregates amyloid fibers. Protein Sci 2012,21(3),373-382","journal-title":"Protein Sci"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"66","DOI":"10.2174\/1874091X01206010066","volume":"6","author":"Zelus C.","year":"2012","unstructured":"Zelus C.; Fox A.; Calciano A.; Faridian B.S.; Nogaj L.A.; Moffet D.A.; Myricetin inhibits islet amyloid polypeptide (iapp) aggregation and rescues living mammalian cells from iapp toxicity. Open Biochem J 2012,6,66-70","journal-title":"Open Biochem J"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"40095","DOI":"10.1038\/srep40095","volume":"7","author":"Paul A.","year":"2017","unstructured":"Paul A.; Kalita S.; Kalita S.; Sukumar P.; Mandal B.; Disaggregation of amylin aggregate by novel conformationally restricted aminobenzoic acid containing \u03b1\/\u03b2 and \u03b1\/\u03b3 hybrid peptidomimetics. Sci Rep 2017,7,40095","journal-title":"Sci Rep"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/cbic.200800762","volume":"10","author":"Mishra R.","year":"2009","unstructured":"Mishra R.; Sellin D.; Radovan D.; Gohlke A.; Winter R.; Inhibiting islet amyloid polypeptide fibril formation by the red wine compound resveratrol. ChemBioChem 2009,10(3),445-449","journal-title":"ChemBioChem"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"21614","DOI":"10.1038\/srep21614","volume":"6","author":"Li X.","year":"2016","unstructured":"Li X.; Wan M.; Gao L.; Fang W.; Mechanism of inhibition of human islet amyloid polypeptide-induced membrane damage by a small organic fluorogen. Sci Rep 2016,6,21614","journal-title":"Sci Rep"},{"key":"ref=107","first-page":"56","volume":"6","author":"Ren B.","year":"2018","unstructured":"Ren B.; Liu Y.; Zhang Y.; Tanshinones inhibit hIAPP aggregation, disaggregate preformed hIAPP fibrils, and protect cultured cells. J Mater Chem B. Royal Society of Chemistry 2018,6(1),56-67","journal-title":"Royal Society of Chemistry"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1002\/anie.201408744","volume":"54","author":"Bram Y.","year":"2015","unstructured":"Bram Y.; Lampel A.; Shaltiel-Karyo R.; Monitoring and targeting the initial dimerization stage of amyloid self-assembly. Angew Chem Int Ed Engl 2015,54(7),2062-2067","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.talanta.2017.05.015","volume":"173","author":"Wang S-T.","year":"2017","unstructured":"Wang S-T.; Lin Y.; Hsu C-C.; Amdursky N.; Spicer C.D.; Stevens M.M.; Probing amylin fibrillation at an early stage via a tetracysteine-recognising fluorophore. Talanta 2017,173,44-50","journal-title":"Talanta"},{"key":"ref=110","first-page":"69","author":"Lukman S.","unstructured":"Lukman S.; Sim K.; Li J.; Chen Y-P.P.; Interacting amino acid preferences of 3d pattern pairs at the binding sites of transient and obligate protein complexes. Proceedings of the 6th Asia-Pacific Bioinformatics Conference ,69-78","journal-title":"Proceedings of the 6th Asia-Pacific Bioinformatics Conference"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"14383","DOI":"10.1002\/anie.201507092","volume":"54","author":"De Carufel C.A.","year":"2015","unstructured":"De Carufel C.A.; Quittot N.; Nguyen P.T.; Bourgault S.; Delineating the role of helical intermediates in natively unfolded polypeptide amyloid assembly and cytotoxicity. Angew Chem Int Ed Engl 2015,54(48),14383-14387","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1039\/C4CC06739H","volume":"51","author":"Zhao D-S.","year":"2015","unstructured":"Zhao D-S.; Chen Y-X.; Li Y-M.; Rational design of an orthosteric regulator of hIAPP aggregation. Chem Commun (Camb) 2015,51(11),2095-2098","journal-title":"Chem Commun (Camb)"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3109\/13506129.2010.530008","volume":"17","author":"Daval M.","year":"2010","unstructured":"Daval M.; Bedrood S.; Gurlo T.; The effect of curcumin on human islet amyloid polypeptide misfolding and toxicity. Amyloid 2010,17(3-4),118-128","journal-title":"Amyloid"},{"key":"ref=114","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2046327","volume":"2016","author":"Pithadia A.","year":"2016","unstructured":"Pithadia A.; Brender J.R.; Fierke C.A.; Ramamoorthy A.; inhibition of iapp aggregation and toxicity by natural products and derivatives. J Diabetes Res 2016,2016","journal-title":"J Diabetes Res"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0022-2836(02)00164-X","volume":"318","author":"Scrocchi L.A.","year":"2002","unstructured":"Scrocchi L.A.; Chen Y.; Waschuk S.; Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis. J Mol Biol 2002,318(3),697-706","journal-title":"J Mol Biol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.chembiol.2005.05.010","volume":"12","author":"Tatarek-Nossol M.","year":"2005","unstructured":"Tatarek-Nossol M.; Yan L-M.; Schmauder A.; Tenidis K.; Westermark G.; Kapurniotu A.; Inhibition of hIAPP amyloid-fibril formation and apoptotic cell death by a designed hIAPP amyloid- core-containing hexapeptide. Chem Biol 2005,12(7),797-809","journal-title":"Chem Biol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/sj.embor.7401034","volume":"8","author":"Monsellier E.","year":"2007","unstructured":"Monsellier E.; Chiti F.; Prevention of amyloid-like aggregation as a driving force of protein evolution. EMBO Rep 2007,8(8),737-742","journal-title":"EMBO Rep"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1002\/1521-3765(20020916)8:18<4285:AID-CHEM4285>3.0.CO;2-0","volume":"8","author":"Rijkers D.T.S.","year":"2002","unstructured":"Rijkers D.T.S.; H\u00f6ppener J.W.M.; Posthuma G.; Lips C.J.M.; Liskamp R.M.J.; Inhibition of amyloid fibril formation of human amylin by N-alkylated amino acid and alpha-hydroxy acid residue containing peptides. Chemistry 2002,8(18),4285-4291","journal-title":"Chemistry"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"12912","DOI":"10.1021\/ja504031d","volume":"136","author":"Susa A.C.","year":"2014","unstructured":"Susa A.C.; Wu C.; Bernstein S.L.; Defining the molecular basis of amyloid inhibitors: human islet amyloid polypeptide-insulin interactions. J Am Chem Soc 2014,136(37),12912-12919","journal-title":"J Am Chem Soc"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1111\/j.1742-4658.2009.07061.x","volume":"276","author":"Cui W.","year":"2009","unstructured":"Cui W.; Ma J-W.; Lei P.; Insulin is a kinetic but not a thermodynamic inhibitor of amylin aggregation. FEBS J 2009,276(12),3365-3371","journal-title":"FEBS J"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/cbdd.12924","volume":"90","author":"Zhou S.","year":"2017","unstructured":"Zhou S.; Wang Q.; Ren M.; Zhang A.; Liu H.; Yao X.; Molecular dynamics simulation on the inhibition mechanism of peptide-based inhibitor of islet amyloid polypeptide (IAPP) to islet amyloid polypeptide (IAPP) oligomers. Chem Biol Drug Des 2017,90(1),31-39","journal-title":"Chem Biol Drug Des"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1586\/14789450.2013.841549","volume":"10","author":"Despa F.","year":"2013","unstructured":"Despa F.; Decarli C.; Amylin: what might be its role in Alzheimer\u2019s disease and how could this affect therapy? Expert Rev Proteomics 2013,10(5),403-405","journal-title":"Expert Rev Proteomics"},{"key":"ref=123","first-page":"12","volume":"Vol. 4","author":"Grizzanti J.","year":"2019","unstructured":"Grizzanti J.; Corrigan R.; Servizi S.; Casadesus G.; Amylin signaling in diabetes and alzheimer\u2019s disease: therapy or pathology? SciAccess Publishers 2019,Vol. 4,12-6","journal-title":"SciAccess Publishers"},{"key":"ref=124","first-page":"497","volume":"66","author":"H\u00f6lscher C.","year":"2014","unstructured":"H\u00f6lscher C.; Drugs developed for treatment of diabetes show protective effects in Alzheimer\u2019s and Parkinson\u2019s diseases. Sheng Li Xue Bao 2014,66(5),497-510","journal-title":"Sheng Li Xue Bao"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neuropharm.2014.07.015","volume":"86","author":"McClean P.L.","year":"2014","unstructured":"McClean P.L.; H\u00f6lscher C.; Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer\u2019s disease. Neuropharmacology 2014,86,241-258","journal-title":"Neuropharmacology"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.23956","volume":"74","author":"Jackson K.","year":"2013","unstructured":"Jackson K.; Barisone G.A.; Diaz E.; Jin L-W.; DeCarli C.; Despa F.; Amylin deposition in the brain: A second amyloid in Alzheimer disease? Ann Neurol 2013,74(4),517-526","journal-title":"Ann Neurol"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1161\/CIRCRESAHA.111.258285","volume":"110","author":"Despa S.","year":"2012","unstructured":"Despa S.; Margulies K.B.; Chen L.; Hyperamylinemia contributes to cardiac dysfunction in obesity and diabetes: a study in humans and rats. Circ Res 2012,110(4),598-608","journal-title":"Circ Res"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/sj.ki.5002305","volume":"72","author":"Gong W.","year":"2007","unstructured":"Gong W.; Liu Z.H.; Zeng C.H.; Amylin deposition in the kidney of patients with diabetic nephropathy. Kidney Int 2007,72(2),213-218","journal-title":"Kidney Int"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neuropharm.2016.07.008","volume":"113","author":"Zhang N","unstructured":"Zhang N; Yang S; Wang C; Zhang J; Huo L; Cheng Y; Multiple target of hAmylin on rat primary hippocampal neurons. Neuropharmacology ,113(Pt A),241-51.2017","journal-title":"Neuropharmacology"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1177\/0271678X16657093","volume":"37","author":"Schultz N.","year":"2017","unstructured":"Schultz N.; Byman E.; Fex M.; Wennstr\u00f6m M.; Amylin alters human brain pericyte viability and NG2 expression. J Cereb Blood Flow Metab 2017,37(4),1470-1482","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.cmet.2015.10.012","volume":"22","author":"Li Z.","year":"2015","unstructured":"Li Z.; Kelly L.; Heiman M.; Greengard P.; Friedman J.M.; Hypothalamic amylin acts in concert with leptin to regulate food intake. Cell Metab 2015,22(6),1059-1067","journal-title":"Cell Metab"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1677\/jme.0.003R001","volume":"3","author":"Ferrier G.J.","year":"1989","unstructured":"Ferrier G.J.; Pierson A.M.; Jones P.M.; Bloom S.R.; Girgis S.I.; Legon S.; Expression of the rat amylin (IAPP\/DAP) gene. J Mol Endocrinol 1989,3(1),R1-R4","journal-title":"J Mol Endocrinol"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3233\/JAD-160800","volume":"56","author":"Mohamed L.A.","year":"2017","unstructured":"Mohamed L.A.; Zhu H.; Mousa Y.M.; Wang E.; Qiu W.Q.; Kaddoumi A.; Amylin Enhances Amyloid-\u03b2 Peptide Brain to Blood Efflux Across the Blood-Brain Barrier. J Alzheimers Dis 2017,56(3),1087-1099","journal-title":"J Alzheimers Dis"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/MED.0b013e32835b896f","volume":"20","author":"Roth J.D.","year":"2013","unstructured":"Roth J.D.; Amylin and the regulation of appetite and adiposity: recent advances in receptor signaling, neurobiology and pharmacology. Curr Opin Endocrinol Diabetes Obes 2013,20(1),8-13","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1100\/tsw.2001.23","volume":"1","author":"Edvinsson L.","year":"2001","unstructured":"Edvinsson L.; Goadsby P.J.; Uddman R.; Amylin: localization, effects on cerebral arteries and on local cerebral blood flow in the cat. ScientificWorldJournal 2001,1,168-180","journal-title":"ScientificWorldJournal"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2337\/diabetes.53.2.474","volume":"53","author":"Janson J.","year":"2004","unstructured":"Janson J.; Laedtke T.; Parisi J.E.; O\u2019Brien P.; Petersen R.C.; Butler P.C.; Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 2004,53(2),474-481","journal-title":"Diabetes"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.neurobiolaging.2013.10.076","volume":"35","author":"Adler B.L.","year":"2014","unstructured":"Adler B.L.; Yarchoan M.; Hwang H.M.; Neuroprotective effects of the amylin analogue pramlintide on Alzheimer\u2019s disease pathogenesis and cognition. Neurobiol Aging 2014,35(4),793-801","journal-title":"Neurobiol Aging"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3389\/fnagi.2014.00186","volume":"6","author":"Qiu W.Q.","year":"2014","unstructured":"Qiu W.Q.; Zhu H.; Amylin and its analogs: a friend or foe for the treatment of Alzheimer\u2019s disease? Front Aging Neurosci 2014,6,186","journal-title":"Front Aging Neurosci"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.trci.2016.12.002","volume":"3","author":"Zhu H.","year":"2017","unstructured":"Zhu H.; Stern R.A.; Tao Q.; An amylin analog used as a challenge test for Alzheimer\u2019s disease. Alzheimers Dement (N Y) 2017,3(1),33-43","journal-title":"Alzheimers Dement (N Y)"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/mp.2014.17","volume":"20","author":"Zhu H.","year":"2015","unstructured":"Zhu H.; Wang X.; Wallack M.; Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer\u2019s disease. Mol Psychiatry 2015,20(2),252-262","journal-title":"Mol Psychiatry"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1021\/bi901751b","volume":"49","author":"Cao P.","year":"2010","unstructured":"Cao P.; Meng F.; Abedini A.; Raleigh D.P.; The ability of rodent islet amyloid polypeptide to inhibit amyloid formation by human islet amyloid polypeptide has important implications for the mechanism of amyloid formation and the design of inhibitors. Biochemistry 2010,49(5),872-881","journal-title":"Biochemistry"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nchem.1293","volume":"4","author":"Middleton C.T.","year":"2012","unstructured":"Middleton C.T.; Marek P.; Cao P.; Two-dimensional infrared spectroscopy reveals the complex behaviour of an amyloid fibril inhibitor. Nat Chem 2012,4(5),355-360","journal-title":"Nat Chem"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.jmb.2009.08.055","volume":"393","author":"Cho W-J.","year":"2009","unstructured":"Cho W-J.; Trikha S.; Jeremic A.M.; Cholesterol regulates assembly of human islet amyloid polypeptide on model membranes. J Mol Biol 2009,393(3),765-775","journal-title":"J Mol Biol"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1021\/acs.biochem.6b01016","volume":"56","author":"Zhang X.","year":"2017","unstructured":"Zhang X.; St Clair J.R.; London E.; Raleigh D.P.; Islet amyloid polypeptide membrane interactions: effects of membrane composition. Biochemistry 2017,56(2),376-390","journal-title":"Biochemistry"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ejmech.2014.05.038","volume":"81","author":"Tomasello M.F.","year":"2014","unstructured":"Tomasello M.F.; Sinopoli A.; Attanasio F.; Molecular and cytotoxic properties of hIAPP17-29 and rIAPP17-29 fragments: a comparative study with the respective full-length parent polypeptides. Eur J Med Chem 2014,81,442-455","journal-title":"Eur J Med Chem"},{"key":"ref=146","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073080","volume":"8","author":"Trikha S.","year":"2013","unstructured":"Trikha S.; Jeremic A.M.; Distinct internalization pathways of human amylin monomers and its cytotoxic oligomers in pancreatic cells. PLoS One 2013,8(9)","journal-title":"PLoS One"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1111\/jcmm.12930","volume":"20","author":"He B.","year":"2016","unstructured":"He B.; Lu C.; Zheng G.; Combination therapeutics in complex diseases. J Cell Mol Med 2016,20(12),2231-2240","journal-title":"J Cell Mol Med"},{"key":"ref=148","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015385","volume":"5","author":"Sulatskaya A.I.","year":"2010","unstructured":"Sulatskaya A.I.; Maskevich A.A.; Kuznetsova I.M.; Uversky V.N.; Turoverov K.K.; Fluorescence quantum yield of thioflavin T in rigid isotropic solution and incorporated into the amyloid fibrils. PLoS One 2010,5(10)","journal-title":"PLoS One"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.bbagen.2013.09.012","volume":"1840","author":"Guo J.","year":"2014","unstructured":"Guo J.; Zhang Y.; Ning L.; Jiao P.; Liu H.; Yao X.; Stabilities and structures of islet amyloid polypeptide (IAPP22-28) oligomers: from dimer to 16-mer. Biochim Biophys Acta 2014,1840(1),357-366","journal-title":"Biochim Biophys Acta"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/173666","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T09:09:34Z","timestamp":1575536974000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/173666\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,13]]},"references-count":149,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2019,11,13]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450120666190719164316","relation":{},"ISSN":["1389-4501"],"issn-type":[{"type":"print","value":"1389-4501"}],"subject":[],"published":{"date-parts":[[2019,11,13]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-04-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}